Tensegrity Pharma
Tokyo
About Tensegrity Pharma
Tensegrity Pharma is the developer of a novel drug designed to minimize bottlenecks and provide innovative value to patients.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $4.2M
- Funding stage: Seed
- Last round: Seed (Jan 2025)
- Website: jp.tensegritypharma.com
- Phone: +81 03-6772-2938
Industries & Categories
Clinical Trials, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/tensegrity-pharma-5771 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.